↑Chano T, Ikegawa S, Kontani K, Okabe H, Baldini N, Saeki Y (Fev 2002). «Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells». Oncogene. 21 (8): 1295–8. PMID11850849. doi:10.1038/sj.onc.1205171
Nagase T, Seki N, Ishikawa K, Ohira M, Kawarabayasi Y, Ohara O, Tanaka A, Kotani H, Miyajima N, Nomura N (Out 1996). «Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain». DNA Research. 3 (5): 321–9, 341–54. PMID9039502. doi:10.1093/dnares/3.5.321
Chano T, Kontani K, Teramoto K, Okabe H, Ikegawa S (julho de 2002). «Truncating mutations of RB1CC1 in human breast cancer». Nature Genetics. 31 (3): 285–8. PMID12068296. doi:10.1038/ng911
Chano T, Ikegawa S, Saito-Ohara F, Inazawa J, Mabuchi A, Saeki Y, Okabe H (Maio de 2002). «Isolation, characterization and mapping of the mouse and human RB1CC1 genes». Gene. 291 (1–2): 29–34. PMID12095676. doi:10.1016/S0378-1119(02)00585-1
Kontani K, Chano T, Ozaki Y, Tezuka N, Sawai S, Fujino S, Saeki Y, Okabe H (novembro de 2003). «RB1CC1 suppresses cell cycle progression through RB1 expression in human neoplastic cells». International Journal of Molecular Medicine. 12 (5): 767–9. PMID14533007. doi:10.3892/ijmm.12.5.767
Bamba N, Chano T, Taga T, Ohta S, Takeuchi Y, Okabe H (Out 2004). «Expression and regulation of RB1CC1 in developing murine and human tissues». International Journal of Molecular Medicine. 14 (4): 583–7. PMID15375585. doi:10.3892/ijmm.14.4.583
Watanabe R, Chano T, Inoue H, Isono T, Koiwai O, Okabe H (Set 2005). «Rb1cc1 is critical for myoblast differentiation through Rb1 regulation». Virchows Archiv. 447 (3): 643–8. PMID15968549. doi:10.1007/s00428-004-1183-1
Melkoumian ZK, Peng X, Gan B, Wu X, Guan JL (Ago 2005). «Mechanism of cell cycle regulation by FIP200 in human breast cancer cells». Cancer Research. 65 (15): 6676–84. PMID16061648. doi:10.1158/0008-5472.CAN-04-4142
Chano T, Saji M, Inoue H, Minami K, Kobayashi T, Hino O, Okabe H (Set 2006). «Neuromuscular abundance of RB1CC1 contributes to the non-proliferating enlarged cell phenotype through both RB1 maintenance and TSC1 degradation». International Journal of Molecular Medicine. 18 (3): 425–32. PMID16865226. doi:10.3892/ijmm.18.3.425
Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M (novembro de 2006). «Global, in vivo, and site-specific phosphorylation dynamics in signaling networks». Cell. 127 (3): 635–48. PMID17081983. doi:10.1016/j.cell.2006.09.026
Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O'Connor L, Li M, Taylor R, Dharsee M, Ho Y, Heilbut A, Moore L, Zhang S, Ornatsky O, Bukhman YV, Ethier M, Sheng Y, Vasilescu J, Abu-Farha M, Lambert JP, Duewel HS, Stewart II, Kuehl B, Hogue K, Colwill K, Gladwish K, Muskat B, Kinach R, Adams SL, Moran MF, Morin GB, Topaloglou T, Figeys D (2007). «Large-scale mapping of human protein-protein interactions by mass spectrometry». Molecular Systems Biology. 3 (1). 89páginas. PMC1847948. PMID17353931. doi:10.1038/msb4100134
Lee YC, Yang VC, Wang TS (Set 2007). «Use of RAPD to detect sodium arsenite-induced DNA damage in human lymphoblastoid cells». Toxicology. 239 (1–2): 108–15. PMID17707572. doi:10.1016/j.tox.2007.06.101